Phytochemistry and Antioxidant, Antimicrobial, and Antidiabetic Potentials of Myrtus communis L. Essential Oil Through In Vitro and In Silico Tests
Advances in Pharmacological and Pharmaceutical Sciences · 2026-01 · 2026 (1)
DOI: 10.1155/adpp/5512543 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Pharmacological and Pharmaceutical Sciences, online erschienen am 02.04.2026. Verfasst von Maroine Flouchi und 12 weiteren Autor:innen. Die Arbeit nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aim
Myrtus communis is a medicinal plant known for its pharmacological potential against cardiovascular, metabolic, and infectious disorders. This study aimed to analyze the phytochemical composition of Myrtus communis essential oil (MCEO) and to evaluate its antioxidant, antimicrobial, and antidiabetic activities through in vitro and in silico approaches.
Methods
The chemical profile of MCEO was determined by gas chromatography–mass spectrometry (GC–MS). Antioxidant activity was assessed using DPPH and FRAP assays. Antimicrobial activity was evaluated against Gram‐positive bacteria ( Bacillus subtilis and Staphylococcus aureus ), Gram‐negative bacteria ( Escherichia coli and Pseudomonas aeruginosa ), and yeasts ( Candida albicans and Candida krusei ) using the broth microdilution method. Antidiabetic activity was tested by measuring the inhibition of α‐amylase and α‐glucosidase. To complete the experimental results, ADMET and molecular docking analyses were performed.
Results
GC–MS analysis identified 1,8‐cineole (54.84%), p ‐cymene (19.42%), and β‐pinene (4.66%) as the major constituents of MCEO. The oil exhibited notable antioxidant activity, showing free radical scavenging in the DPPH assay and strong reducing capacity in the FRAP assay. Antimicrobial testing revealed significant effects against all strains, with minimum inhibitory concentrations (MICs) ranging from 0.019% to 0.312% (v/v) for bacteria and from 0.019% to 0.078% (v/v) for fungi, suggesting potential bactericidal and fungicidal properties. Furthermore, MCEO demonstrated moderate inhibitory activity on α‐amylase (IC 50 = 0.179 ± 0.091 mg/mL) and a statistically significant but lower inhibition of α‐glucosidase (IC 50 = 0.086 ± 0.017 mg/mL, p < 0.001).
Conclusion
The results indicate that MCEO possesses promising antioxidant, antimicrobial, and moderate in vitro α‐amylase and α‐glucosidase inhibitory activity. These findings suggest its potential as a natural source for the development of new pharmacological agents.
Zitieren
APA
Flouchi, M., Fikri-Benbrahim, K., Ouassete, M. E., Elrherabi, A., Bnouham, M., Chebaibi, M., Moussaoui, A. E., Flouchi, R., Allali, A., Aloui, M., Chkirate, K., Achour, R., & Fahsi, K. (2026). Phytochemistry and Antioxidant, Antimicrobial, and Antidiabetic Potentials of Myrtus communis L. Essential Oil Through In Vitro and In Silico Tests. Advances in Pharmacological and Pharmaceutical Sciences, 2026(1). https://doi.org/10.1155/adpp/5512543
Vancouver
Flouchi M, Fikri-Benbrahim K, Ouassete ME, Elrherabi A, Bnouham M, Chebaibi M, et al. Phytochemistry and Antioxidant, Antimicrobial, and Antidiabetic Potentials of Myrtus communis L. Essential Oil Through In Vitro and In Silico Tests. Advances in Pharmacological and Pharmaceutical Sciences. 2026;2026(1). doi:10.1155/adpp/5512543
BibTeX
@article{Flouchi2026,
author = {Flouchi, Maroine and Fikri-Benbrahim, Kawtar and Ouassete, Mohammed El and Elrherabi, Amal and Bnouham, Mohamed and Chebaibi, Mohamed and Moussaoui, Abdelfattah El and Flouchi, Rachid and Allali, Aimad and Aloui, Mourad and Chkirate, Karim and Achour, Redouane and Fahsi, Karim},
title = {Phytochemistry and Antioxidant, Antimicrobial, and Antidiabetic Potentials of Myrtus communis L. Essential Oil Through In Vitro and In Silico Tests},
journal = {Advances in Pharmacological and Pharmaceutical Sciences},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/adpp/5512543}
}
EUVIMED